» Articles » PMID: 37149092

The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets: A Report from the 23rd Annual Harvard Nutrition Obesity Symposium

Abstract

Obesity is increasing at an alarming rate. The effectiveness of currently available strategies for the treatment of obesity (including pharmacologic, surgical, and behavioral interventions) is limited. Understanding the neurobiology of appetite and the important drivers of energy intake (EI) can lead to the development of more effective strategies for the prevention and treatment of obesity. Appetite regulation is complex and is influenced by genetic, social, and environmental factors. It is intricately regulated by a complex interplay of endocrine, gastrointestinal, and neural systems. Hormonal and neural signals generated in response to the energy state of the organism and the quality of food eaten are communicated by paracrine, endocrine, and gastrointestinal signals to the nervous system. The central nervous system integrates homeostatic and hedonic signals to regulate appetite. Although there has been an enormous amount of research over many decades regarding the regulation of EI and body weight, research is only now yielding potentially effective treatment strategies for obesity. The purpose of this article is to summarize the key findings presented in June 2022 at the 23rd annual Harvard Nutrition Obesity Symposium entitled "The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets." Findings presented at the symposium, sponsored by NIH P30 Nutrition Obesity Research Center at Harvard, enhance our current understanding of appetite biology, including innovative techniques used to assess and systematically manipulate critical hedonic processes, which will shape future research and the development of therapeutics for obesity prevention and treatment.

Citing Articles

Food addiction and the physical and mental health status of adults with overweight and obesity.

Zielinska M, Luszczki E, Szymanska A, Deren K PeerJ. 2024; 12:e17639.

PMID: 38952972 PMC: 11216192. DOI: 10.7717/peerj.17639.


Effects of dietary fibre on metabolic health and obesity.

Deehan E, Mocanu V, Madsen K Nat Rev Gastroenterol Hepatol. 2024; 21(5):301-318.

PMID: 38326443 DOI: 10.1038/s41575-023-00891-z.

References
1.
Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky S, Anderson J, Jung S . The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci. 2008; 11(7):752-3. PMC: 2765052. DOI: 10.1038/nn.2139. View

2.
Stunkard A, Harris J, Pedersen N, McClearn G . The body-mass index of twins who have been reared apart. N Engl J Med. 1990; 322(21):1483-7. DOI: 10.1056/NEJM199005243222102. View

3.
Holst J, Andersen D, Grunddal K . Actions of glucagon-like peptide-1 receptor ligands in the gut. Br J Pharmacol. 2021; 179(4):727-742. PMC: 8820219. DOI: 10.1111/bph.15611. View

4.
Bochukova E, Lawler K, Croizier S, Keogh J, Patel N, Strohbehn G . A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome. Cell Rep. 2018; 22(13):3401-3408. PMC: 5896230. DOI: 10.1016/j.celrep.2018.03.018. View

5.
Bickel W, Jarmolowicz D, Mueller E, Gatchalian K, McClure S . Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacology (Berl). 2012; 221(3):361-87. PMC: 4035182. DOI: 10.1007/s00213-012-2689-x. View